Avidity Biosciences ROE - Return on Equity 2019-2024 | RNA

Avidity Biosciences return on equity for the quarter ending September 30, 2024 was -27.61.

  • Avidity Biosciences average return on equity for 2023 was -38.44, a 3.3% decline from 2022.
  • Avidity Biosciences average return on equity for 2022 was -39.75, a 41.76% decline from 2021.
  • Avidity Biosciences average return on equity for 2021 was -28.04, a 77.13% increase from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.

Avidity Biosciences ROE - Return on Equity 2019-2024 | RNA

  • Avidity Biosciences average return on equity for 2023 was -38.44, a 3.3% decline from 2022.
  • Avidity Biosciences average return on equity for 2022 was -39.75, a 41.76% decline from 2021.
  • Avidity Biosciences average return on equity for 2021 was -28.04, a 77.13% increase from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.